|
Reference
|
|
*** (2005-2011) Serbian Law on Healthcare. Official Gazette, 107/2005, 72/2009, 88/2010, 99/2010 and 57/2011, Accessed 08 February 2017., in Serbian
|
|
*** EUROPLAN: Recommendations for the development of national plans and strategies for rare diseases. Available from: www.europlanproject.eu/_newsite_986987/Resources/docs/2008-2011_2.EUROPLANRecommendation.pdf. Accessed 06 January 2017
|
|
*** (2016) Zakon o zdravstvenoj dokumentaciji i evidenciji u oblasti zdravstva. Sl. Glasnik RS, [in Serbian] Accessed 11 January 2017
|
|
*** (2015) Law on prevention and diagnostics of genetic diseases: Genetically caused anomalies and rare diseases. Official Gazette of Republic of Serbia, January. [in Serbian] Accessed 24 February 2017
|
|
Brambati, B. (2000) Prenatal diagnosis of genetic diseases. European Journal of Obstetrics & Gynecology and Reproductive Biology, 90(2): 165-169
|
|
Drezgić, R., Radinković, Ž., Krstić, P. (2012) Horizon of bioethics. Beograd: Centar za filozofiju i društvenu teoriju, in Serbian
|
|
Goločorbin-Kon, S., Vojinović, A., Lalić-Popović, M., Pavlović, N., Mikov, M. (2013) Orphan drugs. Medicinski pregled, vol. 66, br. 9-10, str. 373-378
|
|
Guć-Šćekić, M. (2001) Chromosomal disorders (chromosomopathies). u: Babić M. [ur.] Screening in medicine: The basis of early detection of disease, Belgrade: Yugoslav Foundation Against Cancer, 895-898 pp [in Serbian]
|
1
|
Krajnović, D., Arsić, J., Jocić, D., Georgiev-Milošević, A., Tasić, L., Marinković, V. (2013) Evaluation of pharmacists' knowledge and attitudes regarding rare diseases and orphan drugs. Acta medica Medianae, vol. 52, br. 2, str. 23-32
|
|
Medić, B., Divac, N., Stopić, B., Savić-Vujović, K., Glišić, A., Cerovac, N., Stojanović, R., Srebro, D., Prostran, M. (2016) The attitudes of medical students towards rare diseases: A cross-sectional study. Vojnosanitetski pregled, vol. 73, br. 8, str. 703-713
|
|
Mihailović, Lj., Mihajlović, N. (2009) Human genetics. Ćuprija: School for Applied Studies, in Serbian
|
|
Milošević-Đorđević, O. (2010) Principles of clinical cytogenetics. Kragujevac: Faculty of Medicine, University of Kragujevac, in Serbian
|
|
National Organization for Rare Diseases (NORBS) Available from:
|
|
Remuzzi, G., Garattini, S. (2008) Rare diseases: what's next?. Lancet, 371(9629): 1978-1979
|
2
|
Stojanov, Lj., Marjanović, B. (2002) Hiperfenilalaninemije. u: Stojanov Lj. [ur.] Inherited neurometabolic diseases in children, Beograd: Zavod za udžbenike i nastavna sredstva, str. 61-82
|
|
Strachman, T., Read, A.P. (2004) Human molecular genetics. London: Garland Publishing, 3rd edition
|
1
|
Tucić, N., Matić, G. (2002) O genima i ljudima: Elementi genetike i evolucije. Beograd: Centar za primenjenu psihologiju
|
|
Zlatanović, S. (2013) National plan for rare diseases: Comparative legal review. Strani pravni život, br. 1, str. 290-305
|
|
|
|